Is D-xylose absorption affected in exocrine pancreatic insufficiency?

D-Xylose Absorption is NOT Affected in Pancreatic Insufficiency

D-xylose absorption remains normal in patients with exocrine pancreatic insufficiency because it is absorbed by passive diffusion through the intestinal mucosa and does not require pancreatic enzymes for digestion. This fundamental distinction makes D-xylose testing useful for differentiating small bowel enteropathy from pancreatic maldigestion 1.

Mechanism of D-Xylose Absorption

D-xylose is an inert sugar that:

• Absorbs primarily by passive diffusion through the intestinal barrier
• Does not require enzymatic digestion by pancreatic enzymes
• Reflects mucosal integrity rather than digestive enzyme function 1

This passive absorption mechanism explains why D-xylose testing specifically detects small bowel enteropathy (celiac disease, Crohn's disease, tropical sprue) where the intestinal barrier is damaged, but remains normal when only pancreatic enzyme secretion is impaired 1.

Clinical Evidence Supporting Normal D-Xylose in Pancreatic Disease

Multiple studies confirm preserved D-xylose absorption in pancreatic insufficiency:

• Cystic fibrosis patients with severe pancreatic insufficiency demonstrated normal D-xylose absorption despite significant steatorrhea 2
• Patients with chronic pancreatitis maintain normal xylose absorption even with advanced exocrine dysfunction 3
• A comprehensive review explicitly states that D-xylose testing differentiates patients with small intestinal disease from those with steatorrhea due to pancreatic insufficiency 4

Diagnostic Implications

The D-xylose test is specifically designed to distinguish between two causes of malabsorption:

1. Small bowel enteropathy → Abnormal D-xylose (damaged mucosa cannot absorb)
2. Pancreatic insufficiency → Normal D-xylose (intact mucosa absorbs normally)

This distinction is clinically valuable when evaluating chronic diarrhea and malabsorption, though the test has largely been superseded by more specific diagnostic methods 1.

Important Caveats

While D-xylose absorption is preserved in pure pancreatic insufficiency, abnormal results can occur in specific scenarios:

• Bacterial overgrowth (bacteria consume xylose before absorption) 3
• Liver disease (reduced xylose metabolism)
• Renal dysfunction (affects urinary excretion measurements)
• Ascites (sequestration of xylose)
• Advanced age (physiologic decline in absorption)
• Pancreatic cancer with superior mesenteric vein occlusion (portal venous obstruction causes secondary malabsorption) 5, 4

Current Clinical Practice

The 2003 Gut guidelines explicitly discourage routine use of D-xylose testing due to poor analytical performance in routine practice, despite high sensitivity in research settings 1. Modern practice favors:

• Fecal elastase for pancreatic insufficiency (preferred initial test) 6
• Endoscopic duodenal biopsies for small bowel enteropathy
• Serological testing for celiac disease

The D-xylose test has been largely abandoned because it provides non-specific information and has been superseded by direct access to small bowel histology and specific pancreatic function tests 1.

Bottom Line for Clinical Decision-Making

If you encounter an abnormal D-xylose test in a patient you suspect has pancreatic insufficiency, look for concurrent small bowel disease or one of the confounding factors listed above rather than attributing it to the pancreatic disorder itself. Pure pancreatic exocrine insufficiency does not impair D-xylose absorption 1, 2, 4.